REQUEST A DEMO
Total
USD $0.00
Search more companies

Transcenta Holding Limited (Hong Kong) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Transcenta Holding Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Transcenta Holding Limited focuses on the R&D and manufacturing of biopharmaceuticals in the clinical stage. The company was founded in 2010 and headquartered in Suzhou City, China.

Headquarters
B6-501, 218 Xinghu Street, Biobay
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.

Website: http://www.transcenta.com

Basic Information
Total Employees:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Incorporation Date:
August 20, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
9.03%
Purchase this report to view the information.
8.39%
Purchase this report to view the information.
7.73%
Purchase this report to view the information.
5.96%
Purchase this report to view the information.
5.14%
Subsidiaries
Mabspace Biosciences Co., Limited (Hong Kong SAR, China)
100%
Transcenta Biotherapeutics Inc. (United Kingdom)
100%
Transcenta Therapeutics Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Transcenta Holding Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-87.35%
Total operating revenue
-73.47%
Operating profit (EBIT)
48.96%
EBITDA
54.75%
Net Profit (Loss) for the Period
43.73%
Total assets
-23.67%
Total equity
-27.11%
Operating Profit Margin (ROS)
-2073.66%
Net Profit Margin
-2271.34%
Return on Equity (ROE)
4.38%
Debt to Equity Ratio
3.87%
Quick Ratio
-0.52%
Cash Ratio
-0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?